Multiple perforating and non perforating pilomatricomas in a patient with Churg–Strauss syndrome and Rubinstein−Taybi syndrome
P Bayle,
J Bazex, L Lamant, D Lauque,
C Durieu, B Albes,
Corresponding Author
P Bayle
Services de Dermatologie
* Corresponding author, P Bayle, Place du Baylac, Toulouse Cedex, 31059, tel: +5 6177 9494; fax: +5 6177 7430; E-mail: [email protected]Search for more papers by this authorD Lauque
de Médecine Interne C.H.U.Purpan, Place du Dr Baylac, Toulouse Cedex, 31059, Place du Dr Baylac Toulouse Cedex France.
Search for more papers by this authorP Bayle,
J Bazex, L Lamant, D Lauque,
C Durieu, B Albes,
Corresponding Author
P Bayle
Services de Dermatologie
* Corresponding author, P Bayle, Place du Baylac, Toulouse Cedex, 31059, tel: +5 6177 9494; fax: +5 6177 7430; E-mail: [email protected]Search for more papers by this authorD Lauque
de Médecine Interne C.H.U.Purpan, Place du Dr Baylac, Toulouse Cedex, 31059, Place du Dr Baylac Toulouse Cedex France.
Search for more papers by this authorSUMMARY
We report an unusual association of multiple perforating and non-perforating pilomatricomas with Churg–Strauss syndrome, and a dysmorphic syndrome evocative of Rubinstein-Taybi syndrome. These syndromes may be independent, but these rare diseases and genetic abnormalities may be linked together.
References
- 1 Masi AT, Hunder CG, Lie JT. The American college of Rheumatology. Criteria for the classification of Churg–Strauss syndrome. Arthritis Rheum 1990; 33: 1094–1100.
- 2 Cribier B. Maladies associées aux tumeurs annexielles. I: Tumeurs folliculaires. Ann Dermatol Venereol 1999; 126: 270–279.
- 3 Julian CG, Bowers PW. A clinical review of 209 pilomatricomas. J Am Acad Dermatol 1998; 39: 191–195.
- 4 Alli N, Gungor E, Artuz F. Perforating pilomatricoma. J Am Acad Dermatol 1996; 35: 116–117.
- 5 Moehlenbeck FW. Pilomatrixoma (calcifying epithelioma). Arch Dermatol 1973; 108: 532–534.
- 6 Noguchi H, Kayashima K, Nishiyama S, Ono T. Two cases of pilomatrixoma in Turner's syndrome. Dermatology 1999; 199: 338–340.
- 7 Matsuura H, Hatamochi A, Nakamura Y, Endo H, Shindai H. Multiple pilomatricoma in trisomy. Dermatology 2002; 2O4: 82– 83.
- 8 Cambiaghi S, Ermacora E, Brusasco A, Canzy L, Ruggero C. Multiple pilomatricomas in Rubinstein–Taybi Syndrome: a case report. Pediatric Dermatol 1994; 11: 21–25.
- 9 Masuno M, Imaizumi K, Ishii T, Kuroki Y, Baba N, Tanaka Y. Pilomatrixomas in Rubinstein Taybi syndrome. Am J Med Genet 1995; 56: 112–115.
- 10 Mortier Bonnevalle A, Thomas P, Piette F. Pilomatricomes multiples et poly-épithéliomatose baso–cellulaire: association fortuite ou nouvelle entité. Ann Dermatol Venereol 2001; 128: 3S103.
- 11 Petrij F, Dorsman JC, Dauwerse HG, Giles RH, Peeters T, Hennekam RT. Rubinstein–Taybi syndrome caused by a de novo reciprocal translocation t (2;16 (q36.3; p13.3). Am J Medical Genet 2000; 9: 47–52.
- 12 Cantani A, Gagliesi D. Rubinstein–Taybi syndrome. Review of 732 cases and analysis of the typical traits. Eur Rev Med Pharmacol Sci 1998; 2: 81–87.
- 13 Kanitakis J, Claudy A. Guess what? Eur J Dermatol 2002; 12: 107–109.
- 14 Miller R, Rubinstein J. Tumors in Rubinstein Taybi syndrome. Am J Med Genet 1995; 56: 112–115.
- 15 Villella A, Bialostocky D, Lori E, Meyerson H, Hostoffer RW. Rubinstein–Taybi syndrome with humoral and cellular defects: a case report. Arch Dis Child 2000; 83: 360–361.
- 16 Rivas F, Fragoso R, Ramos-Zepeda R, Vaca G, Hernandez A, Gonzalez-Quiroka G. Deficient cell immunity and mild intermittent hyperaminocidemia in a patient with the Rubinstein–Taybi syndrome. Acta Paediatr Scand 1980; 69: 123–125.
- 17 Barnes PJ, Adcock IM. Transcription factors and asthma. Eur Respir J 1998; 12: 221–234.
- 18 Borrow J, Stanton VP Jr, Anderson JM, Becher R, Behm FG, Chaganti RSK. The translocation t (8; 16) (p11;p13) of acute myeloid leukaemia fuses a putative acetyl–transferase to CREB–binding protein. Nat Genet 1996; 14: 33–41.
- 19 Taki T, Sako M, Tsuchida M, Hayashi Y. The t (11; 16) (q23;p13) translocation in myelodysplastic syndrome fuses the MLL gene to the CBP gene. Blood 1997; 89: 3945–3950.
- 20 Oike Y, Takakura N, Hata A, Kaname T, Azizuki M, Yamaguchi Y. Mice homozygous for a truncated form of CREB-binding protein exhibit defects in hematopoiesis and vasculo-angiogenesis. Blood 1999; 93: 2771–2779.
- 21 Fontes JD, Kanazawa S, Jean D, Peterlin BM. Interactions between the class II transactivator and CREB binding protein increase transcription of major histocompatibility complex class II genes. Mol Cell Biol 1999; 19: 941–947.
- 22 Kretsovali A, Agalioti T, Spilianakis C, Tzortzakaki E, Merika M. Involvement of CREB binding protein in expression of major histocompatibility complex class II genes via interaction with the class II transactivator. Mol Cell Biol 1998; 18: 6777–6783.
- 23 Barnes PJ. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci (Lond) 1998; 94: 557–572.
Citing Literature
